Damon Runyon News
View New Articles By
View New Articles By
Nicknamed Canada’s Nobels, the Gairdner Awards for medical research celebrate the world’s best biomedical and global health scientists. This year Bruce W. Stillman, PhD (Damon Runyon Fellow ’78-81’), President and CEO of Cold Spring Harbor Laboratory, received the honor for his work describing the exact sequence of events involved in DNA replication.
The American Association for Cancer Research announced the winners of this year's Scientific Achievement Awards, which recognize scientists and clinicians who have made significant contributions to our understanding of the diagnosis, prevention, and treatment of cancer. Congratulations to three Damon Runyon Alumni for receiving this honor.
Damon Runyon Clinical Investigator Priscilla K. Brastianos, MD, is driven to find a cure for metastatic cancer. Dr. Brastianos’s grandmother was 23 years old when she felt a breast mass during medical school training and diagnosed herself with breast cancer, only to pass away at 29 when the cancer had metastasized to the spine. Four decades later, her mother faced the same devastating diagnosis. After living through therapy after therapy that failed, she lost the fight to breast cancer that had metastasized to the brain.
By Joseph D. Mancias, MD, PhD, Damon Runyon Rachleff-Innovator at the Dana-Farber Cancer Institute
At the recent Accelerating Cancer Cures Symposium in New York City, I got an inside look at the cutting-edge cancer research presented by fellow Damon Runyon scientists. The unique symposium encourages networking with fellow awardees and pharmaceutical industry leaders. Unlike solitary work in the lab, collaboration provides a synergy of ideas most likely to lead to unexpected paths of discovery.
The Damon Runyon Cancer Research Foundation (Damon Runyon) held the 8th annual Accelerating Cancer Cures Research Symposium. The annual meeting is designed to encourage collaboration between cancer researchers in industry and their counterparts in academia in order to overcome many of the issues that currently impede progress against cancer. Hosted this year by Lilly Oncology, the meeting included academic researchers from top universities and research institutions as well as scientists from Genentech, Gilead Sciences, Merck, Novartis, AbbVie and Amgen.